At a recent event organized by that consortium, the New Jersey Alliance for Clinical and Translational Science(NJACTS), leaders from academia, healthcare, government and the pharmaceutical industry discussed the future of scientific and clinical trial innovation in the state. These new innovations will result from a $33-million grant from the National Institutes of Health (NIH). To read the full story.
Recent Posts
- Anonymous Distribution of Naloxone via Vending Machines Raises Uptake by Ex-Prisoners, Rutgers Researchers Find.
- New NJACTS Publication
- Rutgers Researchers Help Redefine Core Microbiome, Opening New Chapter in Precision Health.
- Interested in Accessing Clinical Data?
- Rutgers Health has big plans to spend $47.5M on new ideas at gleaming new Helix tower.
Categories
- Community (2,072)
- Covid (979)
- CTO Events (5)
- News (2,633)
- Pilots (20)